Akron Children’s Hospital is enrolling patients in a clinical study that aims to help teens suffering from fibromyalgia.
Fibromyalgia causes significant pain and fatigue, which can make ordinary daily activities a struggle. It is most commonly diagnosed in adults.
“Many people are unaware that fibromyalgia occurs in children and teens so many young people go undiagnosed or untreated for this chronic pain condition,” says Mary Toth, MD, director of Rheumatology at Akron Children’s Hospital.
People with fibromyalgia often feel pain when pressure is applied to certain places on the body called “tender points.” Misdiagnosis is common in children and teens because fibromyalgia can be confused with growing pains or chronic fatigue syndrome.
It is not known what causes fibromyalgia but doctors believe it may be hereditary. There is no test to diagnose fibromyalgia, no cure and no approved treatment for it in patients younger than age 18.
However, physicians across the country, including Dr. Toth, are participating in the MyFi clinical study to see if an investigational drug is safe and effective in helping teens manage their fibromyalgia. The drug being studied, milnacipran, is already approved for the management of fibromyalgia in adults.
A teen may be eligible for the study if he or she:
The study may last up to 21 weeks and involve eight or more study visits.
To learn more about fibromyalgia in teens or to see if your child is eligible for the study, call Akron Children’s Rebecca D. Considine Research Institute at 330-543-5012 or email@example.com.
Investigational drug aims to help teens deal with pain, fatigue of fibromyalgia
What to expect when coming to Akron Children's
For healthcare providers and nurses
Residency & Fellowships, Medical Students, Nursing and Allied Health
For prospective employees and career-seekers
Our online community that provides inspirational stories and helpful information.